MARIETTA, Ga., April 20, 2022 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), a transformational placental…
Press release Malmö, Sweden, April 20, 2022 Acarix publishes the annual report for 2021 Today, Wednesday April 20, Acarix is publishing…
CAMBRIDGE, Mass., April 20, 2022 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery…
FLORHAM PARK, N.J., April 20, 2022 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing a…
Company to showcase efficacy of its precision Oral Appliance Therapy devices in treating Obstructive Sleep ApneaSAN FRANCISCO, April 20, 2022 (GLOBE…
Elusys becomes wholly-owned biodefense subsidiary of NightHawk Plans to expand ANTHIM® distribution abroad DURHAM, N.C., April 20, 2022 (GLOBE NEWSWIRE)…
Groundbreaking partnership includes debut of Lowell Farms-branded lighters within the Zippo portfolioSALINAS, Calif., April 20, 2022 (GLOBE NEWSWIRE) -- In a…
New services include pathogen identification, microbiome profiling and rapid turnaround sequencing of clinical isolatesROCKVILLE, Md., April 20, 2022 (GLOBE NEWSWIRE)…
*** David Reardon, Luigi Naldini, Brad Loncar ***MILAN, Italy and NEW YORK, April 20, 2022 (GLOBE NEWSWIRE) -- Genenta Science…
Clinical benefit again observed for OTO-413 versus placebo for multiple efficacy endpoints based on responder analysis at both Days 57…